Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin

Thrombosis and Haemostasis

Volumn 86, Issue 5, 2001, Pages 1221-1228

  Siebenlist, K R ^a   Meh, D A ^a   Mosesson, M W ^a  

^a Schroeder Health Complex 426   (United States)

Author keywords

Factor XIII; Familial mediterranean fever; Fibrinogen; Protransglutaminase; Transglutaminase; 2 Antiplasmin

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; CADAVERINE; CALCIUM ION; CASEIN; DIMER; FIBRIN; FIBRINOGEN; POLYMER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN SUBUNIT; TETRAMER; THROMBIN; CALCIUM; THIOL DERIVATIVE;

ARTICLE; BINDING KINETICS; BLOOD CLOTTING; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; DNA CLEAVAGE; ENZYME ACTIVITY; FAMILIAL MEDITERRANEAN FEVER; PLASMA CHARACTERISTICS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GEL; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SOLUBILITY; ULTRASTRUCTURE;

CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FACTOR XIII; FACTOR XIIIA; FIBRIN; FIBRINOGEN; GELS; HUMAN; KINETICS; PROTEIN BINDING; SOLUBILITY; SULFHYDRYL COMPOUNDS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035159395     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616055     Document Type: Article

References (88)

1. The search for the structure of fibrinogen
2. Covalent structure of fibrinogen
3. The structure and evolution of vertebrate fibrinogen
4. Heterogeneity of human fibrinogen
5. Human fibrinogen heterogeneities III. Identification of γ chain variants
6. Heterogeneities of human fibrinogen I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates
7. Human plasma fibrinogen heterogeneity: Evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (γ′)
8. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (γ′)
9. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains
10. Identification and characterization of the thrombin binding sites on fibrin
11. Adsorption of plasmic fragment D to thrombin modified fibrinogen-sepharose
12. A two-step fibrinogen-fibrin transition in blood coagulation
13. Evidence for four different polymerization sites involved in human fibrin formation
14. Structure of fragment E species from human crosslinked fibrin
15. Fibrin polymerization sites in fibrinogen and fibrin fragments
16. Synthetic peptides modeled on fibrin polymerization sites
17. Fibrinopeptide B and aggregation of fibrinogen
18. Fibrinopeptide B in fibrin assembly and metabolism: Physiologic significance in delayed release of the peptide
19. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin
20. The mechanism of polymerization of fibrinogen
21. Axial period of fibrinogen and fibrin
22. An electron microscopic investigation of the polymerization of bovine fibrin monomer
23. Assembly of fibrin: A light scattering study
24. Structure of the fibrin protofibril
25. Morphology of bovine fibrinogen monomers and fibrin oligomers
26. Morphology of fibrinogen monomers and of fibrin protofibrils
27. Mass-length ratio of fibrin fibres from gel permeation and light scattering
28. Fibrin assembly: A comparison of electron microscopic and light scattering results
29. Crosslink in fibrin polymerized by factor XIII: ε-(γ-glutamyl)lysine
30. The identification of isopeptide crosslinks in insoluble fibrin
31. Identification of the polypeptide chains involved in the cross-linking of fibrin
32. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin
33. The ε-(γ-glutamyl)lysine crosslink and the catalytic role of transglutaminases
34. Cros-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa)
35. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils
36. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin
37. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures
38. The calcium-induced dissociation of human plasma clotting factor XIII
39. Peptide released from plasma fibrin stabilizing factor in the conversion to the active enzyme by thrombin
40. Amino acid sequence of the peptide released from bovine factor XIII following activation by thrombin
41. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin
42. Activation of the fibrin stabilizing factor of plasma by thrombin
43. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity
44. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor
45. 2+-related regulatory function of fibrinogen
46. Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects
47. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen
48. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting
49. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation
50. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII
51. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII
52. Regulation of formation of factor XIIIa by its fibrin substrates
53. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII
54. Fibrin - Recombinant human factor XIIIa-subunit association
55. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin
56. Factor XIII (fibrin-stabilizing factor)
57. FXIII induced gelation of human fibrinogen - An alternative thiol enhanced, thrombin independent pathway
58. The preparation and some properties of fibrinogen precipitated from human plasma by glycine
59. The preparation and properties of human fibrinogen of relatively high solubility
60. Fibrinogen-fibrin interaction
61. Subfractions of human fibrinogen. Preparation and analysis
62. Fibrinoligase. The fibrin stabilizing factor
63. Fibrinase I. Purification of substrate and enzyme
64. Cleavage of structural proteins during assembly of the head of bacteriophage T4
65. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor)
66. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis
67. A filter paper assay for transamidating enzymes using radioactive amine substrates
68. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII)
69. Platelet factor XIII becomes active without the release of activation peptide during platelet activation
70. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets
71. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII
72. Catalytic competence of human α- and γ-thrombin in the activation of fibrinogen and factor XIII
73. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod
74. The action of arvin on fibrin stabilizing factor (factor XIII)
75. Evidence for intramolecular cross-linked Aα-γ chain heterodimers in plasma fibrinogen
76. Biochemical and chromatographic studies on certain activities associated with human fibrinogen preparations
77. Coexisting dysfibrinogenemia (γR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen cedar rapids)
78. Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor
79. The endoendothelial fibrin lining as the crucial barrier and the role of fibrin(Ogenin) gels in controlling transcapillary transport
80. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas
81. Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma
82. Characterization of cryofibrinogen isolated from patients plasma
83. Cryofibrinogen in familial mediterranean fever
84. Evidence for circulating fibrin in familial mediterranean fever
85. The familial mediterranen fever gene - Cloned at last
86. Familial mediterranean fever. A survey of 470 cases and review of the literature
87. Interactions of human fibrinogens with factor XIII: Roles of calcium and the γ' peptide
88. Status of glutathione and other thiols and disulfides in human plasma